➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Harvard Business School
McKesson

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Patent: 9,662,377

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,662,377
Title:Therapeutic composition for treatment of glioblastoma
Abstract: The present invention is directed to compositions and methods for treating an animal diagnosed with Glioblastoma multiforme (GBM).
Inventor(s): Olin; Michael Raymond (Minneapolis, MN), Ohlfest; John R. (Minneapolis, MN), Low; Walter (Minneapolis, MN)
Assignee: REGENTS OF THE UNIVERSITY OF MINNEOSTA (Minneapolis, MN)
Application Number:15/135,292
Patent Claims:see list of patent claims

Details for Patent 9,662,377

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Eisai Inc ONTAK denileukin diftitox VIAL 103767 001 1999-02-05   Start Trial REGENTS OF THE UNIVERSITY OF MINNEOSTA (Minneapolis, MN) 2030-10-25 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Harvard Business School
Dow
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.